Skip to main content
Premium Trial:

Request an Annual Quote

Bruce Myers, Cynthia Eades, Michael Haydock, Gary Clark

Premium

Bruce Myers, CFO of Pharmacopeia, will step down ”to pursue other opportunities” in May, following the company’s annual stockholders’ meeting. The Princeton, NJ-based parent company of Accelrys recently ended a dispute between key stockholders and company officials over the proposed acquisition of Eos Biotechnology, which stockholders ultimately voted against. It was not clear what role this played in Myers’ departure. Pharmacopeia will also lose John Baldwin, chief science and technology officer, who will retire at the end of this month.

 

Maynard, Mass.-based OmniViz has added Cynthia Eades to its staff in the newly created position of chief financial officer and treasurer. Eades joins the company from Webhire, a recruiting software company, where she managed the company’s initial public offering.

 

Michael Haydock has resigned as president and CEO of Cray, “due to differences with the board of directors in how to restore the company to long-term industry leadership,” according to the company. Haydock, who joined Cray in October from IBM, also stepped down from its board of directors. James Rottsolk, formerly president and CEO, has resumed those duties. Rottsolk listed selling the Cray SV1ex system, “particularly into the growing bioinformatics market,” among his goals.

 

OSI Pharmaceuticals of Melville, NY, has named Gary Clark senior director of biostatistics and data management. Clark will oversee biostatistics and data management for OSI’s oncology candidates. Prior to joining OSI, Clark was a professor of medicine at Baylor College of Medicine.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.